Search research articles
Contact Us
Filters
Showing results (11-20 of 77) with videos related to
Page
of 8
Sort By:
European Journal of Gastroenterology & Hepatology
|
August 25, 2018
No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk
Elijah J Mun, Pamela Green, Kristin Berry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 3, 2014
Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis
Kristin Berry, Justin Taylor, Iris W Liou, et al.
Journal of Hepatology
|
May 31, 2019
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
George N Ioannou, Pamela Green, Kathleen F Kerr, et al.
Hepatology Communications
|
August 8, 2019
Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting Antivirals
George N Ioannou, Pamela K Green, Kristin Berry, et al.
Eclinicalmedicine
|
March 9, 2022
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system
George N Ioannou, Emily R Locke, Pamela K Green, et al.
The American Journal of Gastroenterology
|
May 23, 2002
Quality of life in long term survivors of colorectal cancer
Scott D Ramsey, Kristin Berry, Carol Moinpour, et al.
Gastroenterology
|
January 16, 2004
Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer
Scott D Ramsey, Margaret T Mandelson, Kristin Berry, et al.
Plos One
|
September 28, 2018
Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis
George N Ioannou, Pamela Green, Elliott Lowy, et al.
European Journal of Gastroenterology & Hepatology
|
February 15, 2017
Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients
Feng Su, Lauren A Beste, Pamela K Green, et al.
Alimentary Pharmacology & Therapeutics
|
November 28, 2019
Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding
Andrew M Moon, Pamela K Green, Don C Rockey, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 77) with videos related to
Sort By:
Page
of 8
European Journal of Gastroenterology & Hepatology
|
August 25, 2018
No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk
Elijah J Mun, Pamela Green, Kristin Berry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 3, 2014
Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis
Kristin Berry, Justin Taylor, Iris W Liou, et al.
Journal of Hepatology
|
May 31, 2019
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
George N Ioannou, Pamela Green, Kathleen F Kerr, et al.
Hepatology Communications
|
August 8, 2019
Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting Antivirals
George N Ioannou, Pamela K Green, Kristin Berry, et al.
Eclinicalmedicine
|
March 9, 2022
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system
George N Ioannou, Emily R Locke, Pamela K Green, et al.
The American Journal of Gastroenterology
|
May 23, 2002
Quality of life in long term survivors of colorectal cancer
Scott D Ramsey, Kristin Berry, Carol Moinpour, et al.
Gastroenterology
|
January 16, 2004
Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer
Scott D Ramsey, Margaret T Mandelson, Kristin Berry, et al.
Plos One
|
September 28, 2018
Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis
George N Ioannou, Pamela Green, Elliott Lowy, et al.
European Journal of Gastroenterology & Hepatology
|
February 15, 2017
Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients
Feng Su, Lauren A Beste, Pamela K Green, et al.
Alimentary Pharmacology & Therapeutics
|
November 28, 2019
Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding
Andrew M Moon, Pamela K Green, Don C Rockey, et al.
Page
of 8